Difficulty: Medium
Average Score: 69%
Practice
This drug binds bile acids in the GI tract:
Correct answer
A
Rationale
The correct answer is A) Cholestyramine (Questran). Cholestyramine is a bile acid sequestrant that binds bile acids in the GI tract, preventing their reabsorption. By doing so, it helps to lower cholesterol levels by promoting the excretion of bile acids in the feces. This mechanism of action makes it effective in managing hypercholesterolemia.
Option B) Nicotinic acid (Niacin) is a different type of lipid-lowering medication that works by affecting the production of triglycerides and VLDL in the liver. It does not bind bile acids in the GI tract.
Option C) Gemfibrozil (Lopid) is a fibrate medication that works by increasing the activity of lipoprotein lipase, leading to a decrease in triglyceride levels. It does not bind bile acids in the GI tract.
Option D) Probucol (Lorelco) is a lipid-lowering agent that works by increasing the clearance of LDL cholesterol from the blood. It does not bind bile acids in the GI tract.
Understanding the mechanisms of action of different pharmacological treatments is crucial in clinical practice to ensure appropriate drug selection based on the patient's condition. In this case, knowing that cholestyramine binds bile acids in the GI tract helps in understanding its role in managing hypercholesterolemia and differentiating it from other lipid-lowering agents.
Option B) Nicotinic acid (Niacin) is a different type of lipid-lowering medication that works by affecting the production of triglycerides and VLDL in the liver. It does not bind bile acids in the GI tract.
Option C) Gemfibrozil (Lopid) is a fibrate medication that works by increasing the activity of lipoprotein lipase, leading to a decrease in triglyceride levels. It does not bind bile acids in the GI tract.
Option D) Probucol (Lorelco) is a lipid-lowering agent that works by increasing the clearance of LDL cholesterol from the blood. It does not bind bile acids in the GI tract.
Understanding the mechanisms of action of different pharmacological treatments is crucial in clinical practice to ensure appropriate drug selection based on the patient's condition. In this case, knowing that cholestyramine binds bile acids in the GI tract helps in understanding its role in managing hypercholesterolemia and differentiating it from other lipid-lowering agents.